Daily 8: April 2, 2025
GRAND RAPIDS, Mich. (WOOD) — Wednesday on the Daily 8, we're looking at the first measles case in Kent County, changes to Michigan's surrogacy laws, a new candidate making a run for U.S. Senate and more.
You can watch the full Daily 8 for April 2, 2025, in the video player above or check out any of the stories mentioned below:
Each weekday, the Daily 8 brings you the top eight stories we are keeping an eye on in and around West Michigan.
Join us again on Thursday for the Daily 8.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh
BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative medical devices, is proud to announce the launch of its redesigned mobile application, AMT ONE Source®. This strategic update follows a successful website redesign completed late 2024, ensuring that both platforms now offer a cohesive, user-friendly digital experience. Enhancing User Experience Across PlatformsThe redesigned mobile app mirrors the modern, intuitive design language introduced during the website refresh. With a renewed focus on user experience and engagement, the mobile platform now features streamlined interfaces and updated information. "In today's fast-paced healthcare environment, it is essential that our digital platforms are not only reliable but also easy to navigate and visually appealing," said Bill Bentley, National Sales Manager. "Created with our youngest patients in mind, the redesign was thoughtfully developed to be more engaging, age-appropriate, and easy to navigate—helping children and their families feel more supported and empowered throughout their healthcare journey." Key Features and Benefits Unified Design Aesthetic: The mobile app adopts the clean, modern design previously launched on the website, providing a consistent look and feel across all digital touchpoints. Richer Content Experience: The app now features an expanded content database, providing a broader range of resources and information to support users with timely, relevant, and easy-to-access content. Improved Performance: The redesigned app features enhanced performance, with a new backend architecture that allows for faster content updates, easier maintenance, and more frequent improvements to keep the experience fresh and relevant. AMT partnered with Cleveland-Ohio based software company, Stream 9, on the redesign. Their strong track record in software design and development brought deep technical expertise and a strategic approach. "We're fortunate in our business to develop custom software projects for businesses of all kinds; but it's especially rewarding to work on a project that will deliver such a direct benefit to patients and their caregivers. AMT brought a clear vision to the table, and we worked closely together to translate that into a modern, scalable, and user-friendly digital experience," shared Kirk Miesle, Founder of Stream 9. The AMT ONE Source® app is available now on the App Store and Google Play. About AMT: Applied Medical Technology, Inc. (AMT) is a global leader in enteral and surgical devices committed to improving lives through innovation. For 40 years, AMT has bridged the gap between medical technology and patient needs, collaborating with healthcare professionals and users to develop high-quality, life-enhancing solutions. Our holistic approach prioritizes the well-being of the whole person, not just the device they use. View original content to download multimedia: SOURCE Applied Medical Technology, Inc.
Yahoo
an hour ago
- Yahoo
Perimeter Medical Imaging AI to Present at the Life Sciences Virtual Investor Forum on June 12th
TORONTO and DALLAS, June 10, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that its CEO, Adrian Mendes, will present an update on the Company's business at the Life Sciences Virtual Investor Forum on Thursday, June 12, 2025 at 12:30 p.m. Eastern Time. A live stream of the presentation will be available here and on the Investors section of Perimeter's website, where it will also be archived for approximately 90 days. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that was recently evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT, the expected benefits of Perimeter's updated version of its ImgAssist AI, and Perimeter's expectations regarding the outcomes of the clinical trial and future submission to the FDA are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2023, which is available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. CONTACTS: Stephen KilmerInvestor RelationsDirect: 647-872-4849Email: skilmer@ Adrian MendesChief Executive OfficerToll-free: 888-988-7465 (PINK)Email: investors@ View original content to download multimedia: SOURCE Perimeter Medical Imaging AI Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNN
an hour ago
- CNN
Analysis: RFK Jr. made some promises on vaccines to get confirmed. Is he breaking them?
The Trump era is rife with Republicans who abandon their principles in the name of toeing Donald Trump's line. But few have gambled with those principles recently like Louisiana Republican Sen. Bill Cassidy. The chairman of the Senate Health, Education, Labor and Pensions Committee in February played the pivotal role in confirming a longtime purveyor of vaccine misinformation, Robert F. Kennedy Jr., as Health and Human Services secretary. Cassidy did so despite often citing how 30 years of practicing medicine taught him how crucial vaccines are – and despite his very public reservations about Kennedy's views and motivations on the subject. He also did so at a time when vaccine skepticism has risen sharply on the right, meaning Cassidy's strongly held beliefs were already losing ground. At Kennedy's confirmation hearing, Cassidy recalled loading an 18-year-old woman who had hepatitis B onto an ambulance so she could get an emergency liver transplant. 'And as she took off, it was the worst day of my medical career, because I thought $50 of vaccines could have prevented this all,' Cassidy said. 'That was an inflection point in my career.' Cassidy, who faces reelection and likely a primary challenge in 2026, ultimately gave Kennedy a decisive vote, after obtaining what the senator cast as a series of vaccine-related concessions. But pretty much ever since then, Kennedy has tested the spirit of that agreement, if he hasn't violated it outright. Most recently, that took the form of Kennedy on Monday removing all 17 members of an expert panel of advisers that guides the federal government's vaccine recommendations. Many immediately cast this as contrary to what Kennedy promised Cassidy. It's not quite so simple, for reasons we'll get to. But plenty of other actions could fit into that category. For his part, Cassidy on Monday would not tell CNN whether he regrets his vote for Kennedy. Last month, the senator said Kennedy had 'lived up to' the agreement. But at other times, he has taken issue with Kennedy's actions. It's worth a review of what Cassidy said back then – and since. Cassidy laid out the conditions during a speech on the Senate floor. In those February remarks, Cassidy cited the same vaccine advisory panel Kennedy just cleared out. 'If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices' recommendations without changes,' Cassidy said, according to video of his remarks. An old transcript of Cassidy's speech on his own website omitted the word 'recommendations,' leading Kennedy's critics on Monday to accuse him of breaking his word by changing the makeup of the committee itself. But Cassidy's comments pertained to the committee's recommendations. (CNN has reached out to Cassidy's office about the transcript.) Cassidy in an X post Monday expressed concern about what comes next. He cited a 'fear' that 'ACIP will be filled up with people who know nothing about vaccines except suspicion.' 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case,' he added. He declined to go further when pressed by CNN's Manu Raju. Cassidy also said in his February speech that Kennedy had 'committed that he would work within current vaccine approval and safety monitoring systems and not establish parallel systems.' But just in the past two weeks, Kennedy announced changes to the CDC's recommended vaccine schedules without ACIP's input. 'CDC will not remove statements on their website pointing out that vaccines do not cause autism,' Cassidy said in his speech. There is no evidence that the CDC has done this. But Kennedy has taken actions that seem geared toward his longstanding and debunked linking of vaccines to autism, which Cassidy took exception to at Kennedy's confirmation hearing. Most recently, this took the form of launching a 'massive testing and research effort' to find the causes of autism, which critics worry will be geared toward vaccines. And indeed, CNN previously reported HHS had asked the CDC to study vaccines and autism, despite strong evidence there's no link between the two. This is one area where Cassidy has expressed reservations. 'I'll point out that has been clearly laid to rest,' the senator said in April of the supposed link between vaccines and autism, according to The Advocate. 'The more resources we put towards that, we are not putting towards actually finding out what is the cause of autism.' Finally, Cassidy's floor speech suggested Kennedy had provided assurances that he wouldn't use his position to 'wrongfully' create suspicion about vaccines. 'I will watch carefully for any effort to wrongfully sow public fear about vaccines [through] confusing references of coincidence and anecdote,' Cassidy said. 'But my support is built on assurances that this will not have to be a concern …' There is no question Kennedy as HHS secretary has said many things that could undermine confidence in vaccines – often using misinformation. Amid a measles outbreak in Texas, Kennedy wasn't quick to explicitly recommend the measles-mumps-rubella vaccine, while floating unconventional treatments like vitamin A in ways that experts worried would discourage vaccinations. He also made a series of claims about the MMR vaccine that experts reject. These have included that it contains 'fetal debris' and that it 'was never safety tested.' He has also claimed that no childhood vaccine except the Covid-19 vaccine has been fully tested against placebos. But that's not true — something Cassidy pointed out in perhaps the most significant example of him calling out Kennedy. After Kennedy made the claim at a hearing last month, Cassidy returned to the hearing to correct him. 'The secretary made the statement that no vaccines except for Covid have been evaluated against placebo,' Cassidy said. 'For the record, that's not true. The rotavirus, measles and HPV vaccines have been, and some vaccines are tested against previous versions. So, just for the record to set that straight,' Cassidy said. It was the kind of claim that might lead one to wonder whether the guy you elevated to such a powerful position was actually living up to the agreement that got him there. Cassidy doesn't seem willing to go there yet. But all signs are Kennedy is going to continue making him second-guess his choices.
